Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has ...

Recent events indicate that a poorly coordinated process of review by different government agencies may lead to additional delays in the initiation of human testing of gene-therapy protocols.

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

and efficacy of cell-based products Don't missed the opportunity to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy ...

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy that ... group at the CNIC, and the basic–translational group led ...

By studying basic biology in our cells ... Center for Virology and Vaccine Research at BIDMC, member of the Gene and Cell Therapy Institute at Mass General Brigham, and member of the faculty ...

a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic ...